Muir W, Hamlin R
Front Physiol. 2020; 11:222.
PMID: 32296340
PMC: 7137917.
DOI: 10.3389/fphys.2020.00222.
Gao H, Tian Y, Wang W, Yao D, Zheng T, Meng Q
Exp Ther Med. 2016; 11(3):993-997.
PMID: 26998026
PMC: 4774324.
DOI: 10.3892/etm.2015.2962.
Parmley W, Chatterjee K
West J Med. 1980; 133(3):235-6.
PMID: 18748680
PMC: 1272269.
Fennell W
Tex Heart Inst J. 1982; 9(1):61-9.
PMID: 15226814
PMC: 341474.
Tsuruta H, Sato T, Ikeda N
Med Biol Eng Comput. 1994; 32(1):12-8.
PMID: 8182956
DOI: 10.1007/BF02512473.
Intravenous fenoldopam infusion in severe heart failure.
Patel J, Mitha A, Sareli P, de Vaal J
Cardiovasc Drugs Ther. 1993; 7(1):97-101.
PMID: 8097927
DOI: 10.1007/BF00878316.
Ischaemic heart failure: is prevention in sight?.
Chatterjee K, Collins P
Br Heart J. 1993; 70(1):5-7.
PMID: 8037999
PMC: 1025219.
DOI: 10.1136/hrt.70.1.5.
Nitrates in myocardial infarction.
Jugdutt B
Cardiovasc Drugs Ther. 1994; 8(4):635-46.
PMID: 7848898
DOI: 10.1007/BF00877417.
Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
Mehta J, FELDMAN R, Nichols W, Pepine C, Conti C
Br Heart J. 1980; 43(5):556-60.
PMID: 7378216
PMC: 482341.
DOI: 10.1136/hrt.43.5.556.
The changing face of intensive care.
Ports T, Parmley W
Intensive Care Med. 1980; 6(2):85-8.
PMID: 7365110
DOI: 10.1007/BF01683353.
Pharmacokinetic and haemodynamic studies with prazosin in chronic heart failure.
Silke B, Taylor S
Ir J Med Sci. 1981; 150(8):240-7.
PMID: 7287364
DOI: 10.1007/BF02938245.
Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
Massie B, Kramer B, Shen E, Haughom F
Br Heart J. 1981; 45(4):376-84.
PMID: 7225252
PMC: 482537.
DOI: 10.1136/hrt.45.4.376.
Vasodilator therapy for cardiac failure in pediatric practice.
Rao P
Indian J Pediatr. 1982; 49(401):843-8.
PMID: 7182361
DOI: 10.1007/BF02976979.
Pharmacological treatment of pulmonary oedema.
Carlet J, Francoual M, Lhoste F, Regnier B, Lemaire F
Intensive Care Med. 1980; 6(2):113-22.
PMID: 6988485
DOI: 10.1007/BF01683356.
Afterload reduction in the therapy of heart failure.
Fennell W
Ir J Med Sci. 1980; 149(9):333-42.
PMID: 6785251
DOI: 10.1007/BF02939167.
Vasodilator therapy after cardiac surgery: a review of the efficacy and toxicity of nitroglycerin and nitroprusside.
Kaplan J, Finlayson D, Woodward S
Can Anaesth Soc J. 1980; 27(3):254-9.
PMID: 6769567
DOI: 10.1007/BF03007436.
Long-term treatment of congestive heart failure with captopril.
Komajda M, Eugene M, Evans J, Drobinski G, Laurenceau J, Grosgogeat Y
Br J Clin Pharmacol. 1982; 14 Suppl 2:223S-229S.
PMID: 6753904
PMC: 1427509.
DOI: 10.1111/j.1365-2125.1982.tb02081.x.
Pharmacokinetics of oral hydralazine in chronic heart failure.
Hanson A, Johansson B, Wernersson B, Wahlander L
Eur J Clin Pharmacol. 1983; 25(4):467-73.
PMID: 6653641
DOI: 10.1007/BF00542113.
Prazosin for refractory cardiac failure in children.
Netz H, Hagel K, ROHNER G, RAUTENBURG H
Pediatr Cardiol. 1984; 5(4):327-8.
PMID: 6533615
DOI: 10.1007/BF02424981.
Management of the pediatric patient after cardiac surgery.
Lister G
Yale J Biol Med. 1984; 57(1):7-27.
PMID: 6375165
PMC: 2589613.